Jupiter Life Line Hospitals Ltd vs Krishna Institute Of Medical Sciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Jupiter Life Line Hospitals Ltd is ₹ 244.25 as of 23 Oct 15:30 . The P/E Ratio of Jupiter Life Line Hospitals Ltd changed from 44.5 on March 2024 to 43 on March 2026 . This represents a CAGR of -1.14% over 3 yearsThe P/E Ratio of Krishna Institute of Medical Sciences Ltd changed from 33.2 on March 2022 to 103.1 on March 2026 . This represents a CAGR of 25.44% over 5 years The Market Cap of Jupiter Life Line Hospitals Ltd changed from ₹ 7853 crore on March 2024 to ₹ 8344 crore on March 2026 . This represents a CAGR of 2.04% over 3 yearsThe Market Cap of Krishna Institute of Medical Sciences Ltd changed from ₹ 11043 crore on March 2022 to ₹ 24910 crore on March 2026 . This represents a CAGR of 17.67% over 5 years The revenue of Jupiter Life Line Hospitals Ltd for the Sep '26 is ₹ 467.04 crore as compare to the Jun '26 revenue of ₹ 421.57 crore. This represent the growth of 10.79% The revenue of Krishna Institute of Medical Sciences Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 revenue of ₹ 1196 crore. This represent the decline of -100% The ebitda of Jupiter Life Line Hospitals Ltd for the Sep '26 is ₹ 117.39 crore as compare to the Jun '26 ebitda of ₹ 89.86 crore. This represent the growth of 30.64% The ebitda of Krishna Institute of Medical Sciences Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 ebitda of ₹ 240.8 crore. This represent the decline of -100% The net profit of Jupiter Life Line Hospitals Ltd changed from ₹ 44.61 crore to ₹ 56.36 crore over 10 quarters. This represents a CAGR of 9.80% The net profit of Krishna Institute of Medical Sciences Ltd changed from ₹ 95.2 crore to ₹ 0 crore over 10 quarters. This represents a CAGR of -100.00% The Dividend Payout of Jupiter Life Line Hospitals Ltd changed from 4.32 % on March 2024 to 3.43 % on March 2026 . This represents a CAGR of -7.40% over 3 yearsThe Dividend Payout of Krishna Institute of Medical Sciences Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Jupiter Life Line Hospitals Ltd

Jupiter Life Line Hospitals Limited was incorporated in Mumbai, Maharashtra through a Certificate of Incorporation dated November 18, 2002, issued by the RoC, which subsequently, commenced its business operations in December, 2002.
Led by founding Promoter, Dr. Ajay Thakker, the Company is a prominent multi-speciality tertiary and quaternary healthcare service provider in the Mumbai metropolitan area and Western India with total operational bed capacity of 1,194 across three hospitals located in Thane, Pune and Indore under the 'Jupiter' brand.
The Company is constructing a new multi-speciality hospital in Dombivali, Maharashtra with potential capacity of 500 beds.
The Company is also running Fortune Park Lake City Hotel in Thane for promoting medical tourism. The Company follow a patient first' ideology by creating the best infrastructure, technology and support to put the patient first and foremost and be futuristic and innovative in delivery of healthcare.

About Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Limited (KIMS) was erstwhile incorporated as Jagjit Singh and Sons Private Limited', a Private Limited Company on July 26, 1973 in Mumbai.
Subsequently, the name of the Company changed to Krishna Institute of Medical Sciences Private Limited' on January 2, 2004 and further upon its conversion to a Public Company, the name was changed to Krishna Institute of Medical Sciences Limited' on January 29, 2004. The Company is one of the largest corporate groups in India, with hospitals in Telangana, Andhra Pradesh & Maharashtra providing multi-disciplinary integrated services with a focus on tertiary and quaternary healthcare at affordable cost.
It is engaged in rendering medical and healthcare services.
It operate 12 multi-specialty hospitals under the 'KIMS Hospitals' brand, with an aggregate capacity of over 5000 beds.

FAQs for the comparison of Jupiter Life Line Hospitals Ltd and Krishna Institute of Medical Sciences Ltd

Which company has a larger market capitalization, Jupiter Life Line Hospitals Ltd or Krishna Institute of Medical Sciences Ltd?

Market cap of Jupiter Life Line Hospitals Ltd is 8,007 Cr while Market cap of Krishna Institute of Medical Sciences Ltd is 27,978 Cr

What are the key factors driving the stock performance of Jupiter Life Line Hospitals Ltd and Krishna Institute of Medical Sciences Ltd?

The stock performance of Jupiter Life Line Hospitals Ltd and Krishna Institute of Medical Sciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Jupiter Life Line Hospitals Ltd and Krishna Institute of Medical Sciences Ltd?

As of October 25, 2026, the Jupiter Life Line Hospitals Ltd stock price is INR ₹244.25. On the other hand, Krishna Institute of Medical Sciences Ltd stock price is INR ₹666.15.

How do dividend payouts of Jupiter Life Line Hospitals Ltd and Krishna Institute of Medical Sciences Ltd compare?

To compare the dividend payouts of Jupiter Life Line Hospitals Ltd and Krishna Institute of Medical Sciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.